Mathematical model of influenza A virus production in large-scale microcarrier culture.
暂无分享,去创建一个
Udo Reichl | Dietrich Flockerzi | Heiner Sann | D. Flockerzi | U. Reichl | Lars Möhler | H. Sann | L. Möhler
[1] A. Osterhaus,et al. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. , 1998, Journal of virological methods.
[2] A S Perelson,et al. Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. , 2000, The Journal of infectious diseases.
[3] M. Nowak,et al. The dynamics of HTLV-I and the CTL response. , 1999, Immunology today.
[4] G. Whittaker,et al. Early stages of influenza virus entry into Mv-1 lung cells: involvement of dynamin. , 2000, Virology.
[5] M. Betenbaugh,et al. Life and death in mammalian cell culture: strategies for apoptosis inhibition. , 2004, Trends in biotechnology.
[6] D. Endy,et al. Intracellular kinetics of a growing virus: a genetically structured simulation for bacteriophage T7. , 1997, Biotechnology and bioengineering.
[7] F. Dorner,et al. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. , 1998, Vaccine.
[8] A. Fooks,et al. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. , 2001, Vaccine.
[9] M L Shuler,et al. A mathematical model of the trafficking of acid-dependent enveloped viruses: application to the binding, uptake, and nuclear accumulation of baculovirus. , 1997, Biotechnology and bioengineering.
[10] G. Neumann,et al. Reverse genetics of influenza virus. , 2001, Virology.
[11] S. Nir,et al. Interactions of influenza virus with cultured cells: detailed kinetic modeling of binding and endocytosis. , 1999, Biochemistry.
[12] J E Bailey,et al. Modeling the population dynamics of baculovirus‐infected insect cells: Optimizing infection strategies for enhanced recombinant protein yields , 1992, Biotechnology and bioengineering.
[13] M L Shuler,et al. A model of the binding, entry, uncoating, and RNA synthesis of Semliki Forest virus in baby hamster kidney (BHK‐21) cells , 1995, Biotechnology and bioengineering.
[14] Beda Joos,et al. Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells. , 2001 .
[15] Graham F. Medley,et al. Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control , 2001, Nature Medicine.
[16] A. Perelson,et al. Optimizing within-host viral fitness: infected cell lifespan and virion production rate. , 2004, Journal of theoretical biology.
[17] J. Kehren,et al. bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation , 1996, Journal of virology.
[18] M. Tabata,et al. Analysis of the infection system of human T‐cell leukaemia virus type I based on a mathematical epidemic model , 2001, Statistics in medicine.
[19] U. Reichl,et al. Development of bioprocess concepts on vaccine production : influenza virus as an example , 2001 .
[20] G. Neumann,et al. Genetic engineering of influenza and other negative-strand RNA viruses containing segmented genomes. , 1999, Advances in virus research.
[21] A. Osterhaus,et al. Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium. , 1999, Vaccine.
[22] U Reichl,et al. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. , 2004, Vaccine.
[23] Z Xu,et al. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china. , 2000, International journal of epidemiology.
[24] S. Pleschka,et al. Negative-strand RNA viruses: genetic engineering and applications. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] Patrick W Nelson,et al. Mathematical analysis of delay differential equation models of HIV-1 infection. , 2002, Mathematical biosciences.
[26] T. Parslow,et al. Evidence for Segment-Nonspecific Packaging of the Influenza A Virus Genome , 2002, Journal of Virology.
[27] C. D. de Gooijer,et al. A structured dynamic model for the baculovirus infection process in insect‐cell reactor configurations , 1992, Biotechnology and bioengineering.
[28] Morgan H. McCoy,et al. Caspase activation in equine influenza virus induced apoptotic cell death. , 2002, Veterinary microbiology.
[29] J. Yin,et al. Quantitative intracellular kinetics of HIV type 1. , 1999, AIDS research and human retroviruses.
[30] A. Attwell,et al. Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture. , 1995, Vaccine.
[31] Achim Kienle,et al. Object-oriented modeling of distillation processes , 1999 .
[32] C. S. Sanderson,et al. Structured modeling of recombinant protein production in batch and fed-batch culture of baculovirus-infected insect cells , 2004, Cytotechnology.
[33] Martin H. Koldijk,et al. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. , 2001, Vaccine.
[34] A. Garfinkel,et al. Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics. , 1999, Clinical immunology.